Treatment of Urothelial Cancer in Elderly Patients: Focus on Immune Checkpoint Inhibitors.

Abstract:

:Urothelial carcinoma, or bladder cancer, is a malignancy that most commonly affects older patients. The median age at diagnosis is 73 years, and care of these patients requires consideration not just of the disease-related factors such as stage and histology, but also of patient-related factors. Many of these patients have concurrent medical morbidities and additional changes related to the aging process. Older patients with cancer are a unique population requiring additional considerations and assessment in treatment decision-making. It is important to look beyond chronologic age. The traditional treatment for advanced disease has relied on platinum-based chemotherapy. These multi-agent regimens require consideration of baseline organ function as well as competing conditions that may heighten toxicity. The advent of a new class of cancer therapeutics, the immune checkpoint inhibitors, has changed the care of patients with advanced disease considerably. These immunotherapeutics have been approved for treating patients with disease progression on chemotherapy, or those who are ineligible (or unfit) to receive cisplatin-based therapy. This expansion of the population of patients eligible for treatment has great applicability to the unique considerations in an older patient population. In general, these new immunotherapies are well tolerated and effective in this group of patients.

journal_name

Drugs Aging

journal_title

Drugs & aging

authors

Jodon G,Fischer SM,Kessler ER

doi

10.1007/s40266-018-0540-8

subject

Has Abstract

pub_date

2018-05-01 00:00:00

pages

409-421

issue

5

eissn

1170-229X

issn

1179-1969

pii

10.1007/s40266-018-0540-8

journal_volume

35

pub_type

杂志文章,评审
  • Optimal pharmacotherapeutic management of acute lymphoblastic leukaemia in the elderly.

    abstract::The main characteristic of acute lymphoblastic leukaemia (ALL) in the elderly is its dismal prognosis. However, other than a lower incidence of T-cell ALL and a greater likelihood of unfavourable chromosomal abnormalities, the clinical and biological characteristics of Philadelphia chromosome-negative (Ph-) ALL in the...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11592850-000000000-00000

    authors: Rousselot P,Delannoy A

    更新日期:2011-09-01 00:00:00

  • Scabies outbreaks in nursing homes for the elderly: recognition, treatment options and control of reinfestation.

    abstract::The scabies mite is an ectoparasite able to infest humans. Its clinical presentation is typical, although in immunocompromised, mentally retarded and elderly patients the clinical presentation may be altered. Diagnosis may therefore be difficult in such patient groups, who often reside in nursing homes. Because delay ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200825040-00003

    authors: Tjioe M,Vissers WH

    更新日期:2008-01-01 00:00:00

  • Treatment of systemic fungal infections in older patients: achieving optimal outcomes.

    abstract::Systemic fungal infections are an increasing problem in older adults. For several of the endemic mycoses, this increase is the result of increased travel and leisure activities in areas endemic for these fungi. Immunosuppressive agents, care in an intensive care unit, and invasive devices all contribute to infection w...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200118050-00002

    authors: Kauffman CA,Hedderwick SA

    更新日期:2001-01-01 00:00:00

  • Bacterial skin infections in the elderly: diagnosis and treatment.

    abstract::Skin and soft tissue infections are quite common in elderly people. A number of special conditions and circumstances need to be considered in the diagnosis and therapy. It is important to try to establish the causative organism, exclude other cutaneous disorders and identify precipitating factors. Treatment modalities...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200219050-00002

    authors: Laube S,Farrell AM

    更新日期:2002-01-01 00:00:00

  • Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

    abstract::Man and higher primates have adrenals that secrete large amounts of dehydroepiandrosterone (DHEA) [prasterone] and its sulphate (DHEAS) [PB 008]. A remarkable feature of plasma DHEAS levels in humans is their great decrease with aging. Researchers have postulated that this age-related decline of DHEAS levels may expla...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320130-00001

    authors: Legrain S,Girard L

    更新日期:2003-01-01 00:00:00

  • Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states.

    abstract::Amitriptyline is a tricyclic antidepressant agent which also has analgesic properties. Whether its analgesic effects are linked to its mood-altering activity or attributable to a discrete pharmacological action (or a combination of both) is unknown. Clinical trials demonstrate that oral amitriptyline achieves at least...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199608060-00008

    authors: Bryson HM,Wilde MI

    更新日期:1996-06-01 00:00:00

  • Benzodiazepines and injurious falls in community dwelling elders.

    abstract:BACKGROUND:Benzodiazepines are frequently used medications in the elderly, in whom they are associated with an increased risk of falling, with sometimes dire consequences. OBJECTIVE:To estimate the impact of benzodiazepine-associated injurious falls in a population of elderly persons. METHOD:A nested case-control stu...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200825010-00007

    authors: Pariente A,Dartigues JF,Benichou J,Letenneur L,Moore N,Fourrier-Réglat A

    更新日期:2008-01-01 00:00:00

  • Issues in the perioperative management of the elderly patient with cardiovascular disease.

    abstract::The elderly patient may show normal physiological changes of the cardiovascular and respiratory systems that accompany aging, as well as features of intrinsic cardiac disease. The latter include: a past history of myocardial infarction or ischaemic heart disease; history of congestive cardiac failure; angina; arterial...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200219060-00003

    authors: Sear JW,Higham H

    更新日期:2002-01-01 00:00:00

  • Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.

    abstract::The incidence of both systolic and diastolic hypertension is increased in elderly patients, therefore antihypertensive drugs are commonly used in this population. In addition to changes in blood pressure, the aging process also causes numerous changes in other physiological parameters, resulting in altered pharmacokin...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199101030-00004

    authors: Piepho RW,Fendler KJ

    更新日期:1991-05-01 00:00:00

  • Current recommendations for the prevention and treatment of influenza in the older population.

    abstract::Influenza is a major cause of morbidity and mortality in the elderly. Influenza vaccine is recommended for people aged 65 years and older and those in long term care. Currently only 30% of high risk persons are vaccinated. Vaccination generally stimulates an adequate immune response, is well tolerated and is to be enc...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199101060-00003

    authors: Gross PA

    更新日期:1991-11-01 00:00:00

  • Interventions to Improve Medicines Management for People with Dementia: A Systematic Review.

    abstract:BACKGROUND:The importance of optimising medicines management for people with dementia has been emphasised through research and policy. However, evidence is currently lacking regarding how to achieve this in this patient population. OBJECTIVE:The aim was to assess the effectiveness of medicines management interventions...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-017-0505-3

    authors: McGrattan M,Ryan C,Barry HE,Hughes CM

    更新日期:2017-12-01 00:00:00

  • Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy.

    abstract:BACKGROUND:Patients hospitalised with severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2; coronavirus 2019 disease (COVID-19)] infection are frequently older with co-morbidities and receiving polypharmacy, all of which are known risk factors for drug-drug interactions (DDIs). The pharmacological burden may be ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-020-00812-8

    authors: Cattaneo D,Pasina L,Maggioni AP,Giacomelli A,Oreni L,Covizzi A,Bradanini L,Schiuma M,Antinori S,Ridolfo A,Gervasoni C

    更新日期:2020-12-01 00:00:00

  • Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs.

    abstract::Elderly rheumatoid arthritis (RA) is classified into two clinical subsets, elderly-onset RA (EORA) and younger-onset elderly RA. With the improvement of life expectancy in the general population and advent of the super-aging society, the number of patients with EORA is anticipated to increase. Both large and small joi...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-015-0341-2

    authors: Sugihara T,Harigai M

    更新日期:2016-02-01 00:00:00

  • Meglitinide analogues in the treatment of type 2 diabetes mellitus.

    abstract::Type 2 diabetes mellitus is a complex heterogenous metabolic disorder in which peripheral insulin resistance and impaired insulin release are the main pathogenetic factors. The rapid response of the pancreatic beta-cells to glucose is already markedly disturbed in the early stages of type 2 diabetes mellitus. The cons...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200017050-00007

    authors: Landgraf R

    更新日期:2000-11-01 00:00:00

  • Acute cough in the elderly: aetiology, diagnosis and therapy.

    abstract::Although the frequency of physician consultations and the sale of over-the-counter remedies establish the high prevalence of acute cough in the elderly, epidemiological studies have tended to be imprecise. However, respiratory tract infections in nose, larynx and/or bronchi, either viral or bacterial or both, are by f...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200421040-00003

    authors: Widdicombe J,Kamath S

    更新日期:2004-01-01 00:00:00

  • The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease.

    abstract::Blood pressure levels are strongly predictive of the risks of first-ever and recurrent stroke. The benefits of blood pressure-lowering therapy for the prevention of fatal and non-fatal stroke in middle-aged individuals are well established. However, until recently, there has been uncertainty about the consistency of s...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320040-00001

    authors: Ratnasabapathy Y,Lawes CM,Anderson CS

    更新日期:2003-01-01 00:00:00

  • Anticholinergic component of the Drug Burden Index and the Anticholinergic Drug Scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study.

    abstract:BACKGROUND:Older people are exposed to multiple medicines that possess anticholinergic properties. The use of anticholinergic medicines is associated with the risk of morbidity, mortality and cognitive decline, particularly in older people. Anticholinergic exposure can be measured using tools such as the Drug Burden In...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-013-0111-y

    authors: Narayan SW,Hilmer SN,Horsburgh S,Nishtala PS

    更新日期:2013-11-01 00:00:00

  • Use of Medicines that May Exacerbate Heart Failure in Older Adults: Therapeutic Complexity of Multimorbidity.

    abstract:BACKGROUND:Multimorbidity is common in older patients with heart failure (HF), complicating therapeutic management and increasing the risk of harm. OBJECTIVE:This study sought to examine the prevalence of medicines for the treatment of comorbid conditions potentially associated with harm in older people, before and af...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-019-00645-0

    authors: Caughey GE,Shakib S,Barratt JD,Roughead EE

    更新日期:2019-05-01 00:00:00

  • Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.

    abstract::The focus of this review is hormone replacement therapy (HRT) with continuous oral 17 beta-estradiol (herein referred to as estradiol) 2 mg/day plus sequential oral dydrogesterone 10 or 20 mg/day for 14 days of each 28-day cycle. According to data from nonblind trials, this regimen relieves climacteric symptoms, prese...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199711040-00006

    authors: Foster RH,Balfour JA

    更新日期:1997-10-01 00:00:00

  • Vitreous haemorrhage in elderly patients: management and prevention.

    abstract::Vitreous haemorrhage can be caused by a disruption of normal retinal vessels, bleeding from diseased retinal vessels, bleeding from abnormal new vessels or extension of haemorrhage through the retina from other sources. In the elderly, vitreous haemorrhage usually occurs spontaneously and only occurs occasionally as a...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320090-00003

    authors: Manuchehri K,Kirkby G

    更新日期:2003-01-01 00:00:00

  • Diagnostic and pharmacological approaches in Alzheimer's disease.

    abstract::Alzheimer's disease is a chronic progressive disease affecting higher intellectual functioning. The clinical diagnosis is made when the onset of illness is insidious, the course slowly progressive and all the treatable causes of dementia have been ruled out. The use of more stringent criteria has improved clinical dia...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199101020-00006

    authors: Hermann C,Stern RG,Losonzcy MF,Jaff S,Davidson M

    更新日期:1991-03-01 00:00:00

  • Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.

    abstract::Lisinopril, the lysine analogue of enalaprilat, is a long-acting angiotensin converting enzyme (ACE) inhibitor which is administered once daily by mouth. The efficacy of lisinopril in reducing blood pressure is well established in younger populations, and many trials now show it to be effective in lowering blood press...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199710020-00006

    authors: Langtry HD,Markham A

    更新日期:1997-02-01 00:00:00

  • Safety of Paracetamol in Osteoarthritis: What Does the Literature Say?

    abstract::Osteoarthritis (OA) is a major cause of pain and physical disability in adults, and an increasingly common disease given its associations with aging and a growing obese/overweight population. Paracetamol is widely recommended for analgesia at an early stage in the management of OA, and, although frequently prescribed,...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-019-00658-9

    authors: Conaghan PG,Arden N,Avouac B,Migliore A,Rizzoli R

    更新日期:2019-04-01 00:00:00

  • Multiple sclerosis in the elderly patient.

    abstract::Multiple sclerosis (MS) is an acquired inflammatory demyelinating disease of the CNS that is typically diagnosed in the second or third decade of life. It is generally believed that over the last few decades the life expectancy of patients with adult onset MS (AOMS) has approached that of the general population as a r...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11532120-000000000-00000

    authors: Awad A,Stüve O

    更新日期:2010-04-01 00:00:00

  • Economic evaluation of ropinirole prolonged release for treatment of Parkinson's disease in the Netherlands.

    abstract:BACKGROUND:By using the findings obtained from the PREPARED study, we aimed to estimate the cost effectiveness of ropinirole prolonged release (PR) [Requip-Modutab(®)] in Parkinson's disease (PD) versus ropinirole immediate release (IR). In the PREPARED study, ropinirole PR provided a significantly greater improvement ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-013-0150-4

    authors: van Boven JF,Novak A,Driessen MT,Boersma C,Boomsma MM,Postma MJ

    更新日期:2014-03-01 00:00:00

  • Xerostomia and hyposalivation: causes, consequences and treatment in the elderly.

    abstract::Xerostomia and salivary gland hypofunction (SGH) are prevalent in elderly populations, causing much discomfort and even difficulties in eating. SGH also increases the occurrence and severity of oral diseases and makes the patient susceptible to candidiasis. The principal causes of SGH and xerostomia are systemic disea...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199915020-00004

    authors: Närhi TO,Meurman JH,Ainamo A

    更新日期:1999-08-01 00:00:00

  • NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies.

    abstract:BACKGROUND:Several studies have suggested that NSAID use may modify the risk of developing Parkinson's disease (PD). OBJECTIVE:Our aim was to conduct a meta-analysis of observational studies evaluating NSAID use and the risk of PD. METHODS:We systematically searched MEDLINE (1966-November 2008), EMBASE (1980-November...

    journal_title:Drugs & aging

    pub_type: 杂志文章,meta分析,评审

    doi:10.2165/11316780-000000000-00000

    authors: Samii A,Etminan M,Wiens MO,Jafari S

    更新日期:2009-01-01 00:00:00

  • Gerontology forum: an update on the literature.

    abstract::New treatments and treatment protocols for diseases affecting the elderly are evolving as we strive to meet the needs of an aging society. To help you keep up to date with the latest advances worldwide on all aspects of drug therapy and patient management, this section of the journal brings you information selected fr...

    journal_title:Drugs & aging

    pub_type:

    doi:10.2165/00002512-200623080-00005

    authors:

    更新日期:2006-01-01 00:00:00

  • Use of low-molecular-weight heparins and new anticoagulants in elderly patients with renal impairment.

    abstract::Elderly people with renal impairment are at high risk for venous thromboembolism (VTE) and acute coronary syndromes (ACS); however, they are also at increased risk for bleeding complications. Evidence-based data for the management of anticoagulation in elderly patients with severe renal impairment, in particular, are ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11586730-000000000-00000

    authors: Samama MM

    更新日期:2011-03-01 00:00:00

  • Associations between the Drug Burden Index, Potentially Inappropriate Medications and Quality of Life in Residential Aged Care.

    abstract:BACKGROUND:Inappropriate polypharmacy may negatively impact the quality of life of residents in aged care facilities, but it remains unclear which medications may influence this reduced quality of life. OBJECTIVE:The objective of this study was to examine whether the Drug Burden Index and potentially inappropriate med...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-017-0513-3

    authors: Harrison SL,Kouladjian O'Donnell L,Bradley CE,Milte R,Dyer SM,Gnanamanickam ES,Liu E,Hilmer SN,Crotty M

    更新日期:2018-01-01 00:00:00